See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Diabetes Dietary Supplement

Uri Man

Diabetes Dietary Supplement

Teaching Aids for Health Educators

Barbara George

Teaching Aids for Health Educators

David Kendall speaks about Symlin

David M. Kendall M.D.

David Kendall speaks about Symlin

diabetes medicine

Updated 1 week ago
Diabetes Patients On Metformin Show Better Lipid Profile
Sep 10, 2014 | 
Chinese researchers found that type 2 diabetes patients taking metformin – one of the first lines of defense in the treatment of the disease - attained a better overall lipid profile compared with those who took glipizide.
Eylea Earns FDA Approval To Treat Diabetic Macular Edema
Sep 3, 2014 | 
The U.S. Food and Drug Administration has approved the eye drug Eylea for the treatment of diabetic macular edema, according to the drug makers Regeneron Pharmaceuticals, Inc.
DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Diabetes Dietary Supplement

Uri Man

Diabetes Dietary Supplement

Teaching Aids for Health Educators

Barbara George

Teaching Aids for Health Educators

David Kendall speaks about Symlin

David M. Kendall M.D.

David Kendall speaks about Symlin

Weekly Dulaglutide Performs Well in Comparison to Daily Liraglutide
Aug 1, 2014 | 
A comparison of the effects on A1c between users of once-weekly dulaglutide (made by Eli Lilly and Company) and once-daily liraglutide (sold as Victoza from Novo Nordisk) shows that both drugs have very similar effects.
Novo Nordisk Introduces New Insulin Device to U.S. Market
Jul 26, 2014 | 
Novo Nordisk has introduced the Levemir® FlexTouch® prefilled insulin delivery device to the U.S. market. The device, filled with insulin detemir [rDNA origin], the first of its kind that does not use a pushbutton extension. In a conventional insulin delivery device, a pushbutton extends out from the device. If the called-for dose is large, an extension may cause problems for the user.
What Type 2s Can Do When Blood Sugar Soars
Jul 16, 2014 | 
The emergency condition most type 2s dread is hypoglycemia, where plummeting blood sugar levels can bring on a dangerous semi-conscious state, and even coma or death.
 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.